OR4Q3

From WikiMD's Food, Medicine & Wellness Encyclopedia

OR4Q3 is a gene that encodes the olfactory receptor, family 4, subfamily Q, member 3 in humans. The olfactory receptor proteins are members of a large family of G-protein coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.

Function[edit | edit source]

The OR4Q3 gene is part of the olfactory receptor gene family, which is the largest gene family in the human genome. The proteins encoded by these genes are responsible for the recognition and transduction of odorant signals, which are mediated by G proteins.

File:Olfactory receptors.jpg
Olfactory receptors are responsible for the recognition and G protein-mediated transduction of odorant signals.

Structure[edit | edit source]

The OR4Q3 gene is located on chromosome 14q11.1 and is composed of a single coding exon. The protein encoded by this gene shares a 7-transmembrane domain structure with many neurotransmitter and hormone receptors.

Clinical Significance[edit | edit source]

While the specific clinical significance of OR4Q3 is not yet fully understood, olfactory receptors in general have been implicated in a variety of diseases and conditions, including anosmia (loss of smell), and neurodegenerative diseases such as Parkinson's disease and Alzheimer's disease.

Research[edit | edit source]

Research into the OR4Q3 gene and its encoded protein is ongoing, with scientists seeking to better understand its function and potential role in disease.

See Also[edit | edit source]

References[edit | edit source]


Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Prab R. Tumpati, MD